PTX 0.00% 4.7¢ prescient therapeutics limited

Ann: PTX unveils new clinic-ready CAR-T enhancement platform, page-24

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,368 Posts.
    lightbulb Created with Sketch. 2037
    What a great pivot for PTX. Its becoming a stop shop for CarT treatment enhancement. I like how this cell improvement and OmniCar can be licenced to third parties either together or individually. The market potential is huge.

    Will be interesting to see this at work when the OmniCar GBM trial hits arms.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.